These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15390346)

  • 1. Novel percutaneous adventitial drug delivery system for regional vascular treatment.
    Ikeno F; Lyons J; Kaneda H; Baluom M; Benet LZ; Rezaee M
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):222-30. PubMed ID: 15390346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local catheter-based delivery of antithrombotic or antiproliferative drugs: a new concept for prevention of restenosis.
    Herdeg C; Goehring-Frischholz K; Zuern C; Geisler T; Hartmann U; Hoevelborn T; Haase KK; Gawaz M
    Thromb Res; 2008; 123(2):236-43. PubMed ID: 18452977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries.
    Posa A; Hemetsberger R; Petnehazy O; Petrasi Z; Testor M; Glogar D; Gyöngyösi M
    Coron Artery Dis; 2008 Jun; 19(4):243-7. PubMed ID: 18480668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment.
    Olsen TW; Feng X; Wabner K; Conston SR; Sierra DH; Folden DV; Smith ME; Cameron JD
    Am J Ophthalmol; 2006 Nov; 142(5):777-87. PubMed ID: 16989764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stent update 2007: part II: Unsettled issues.
    Daemen J; Serruys PW
    Circulation; 2007 Aug; 116(8):961-8. PubMed ID: 17709651
    [No Abstract]   [Full Text] [Related]  

  • 7. Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions.
    Han YL; Wang SL; Jing QM; Yu HB; Wang B; Ma YY; Luan B; Wang G
    Chin Med J (Engl); 2007 Apr; 120(7):552-6. PubMed ID: 17442201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual balloon catheter.
    Gunn J; Cumberland DC
    Semin Interv Cardiol; 1996 Mar; 1(1):31-3. PubMed ID: 9552484
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.
    Mita AC; Olszanski AJ; Walovitch RC; Perez RP; MacKay K; Tuck DP; Simmons C; Hammond S; Mita MM; Beeram M; Stone AJ; Rowinsky EK; Lewis LD
    Clin Cancer Res; 2007 Jun; 13(11):3293-301. PubMed ID: 17545535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the percutaneous intramyocardial injection for local myocardial treatment.
    Rezaee M; Yeung AC; Altman P; Lubbe D; Takeshi S; Schwartz RS; Stertzer S; Altman JD
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):271-6. PubMed ID: 11387620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.
    Fuchs S; Dib N; Cohen BM; Okubagzi P; Diethrich EB; Campbell A; Macko J; Kessler PD; Rasmussen HS; Epstein SE; Kornowski R
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):372-8. PubMed ID: 16892433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
    Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Colombo A; Leon MB; Moses JW; Iversen P
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):389-94. PubMed ID: 15736246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary stenting with M-Guard: feasibility and safety porcine trial.
    Kaluski E; Groothuis A; Klapholz M; Seifart P; Edelman E
    J Invasive Cardiol; 2007 Aug; 19(8):326-30. PubMed ID: 17712199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular treatment of experimental aneurysms using a combination of thermoreversible gelation polymer and protection devices: feasibility study.
    Takao H; Murayama Y; Yuki I; Ishibashi T; Ebara M; Irie K; Yoshioka H; Mori Y; Vinuela F; Abe T
    Neurosurgery; 2009 Sep; 65(3):601-9; discussion 609. PubMed ID: 19687707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel catheter system for percutaneous intracoronary artery cardiomyoplasty.
    Tsuchikane E; Taketani S; Shimogami M; Sawa Y; Katoh O
    J Invasive Cardiol; 2008 Jul; 20(7):357-60. PubMed ID: 18599895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of pimecrolimus-eluting stents in porcine coronary arteries.
    Waksman R; Pakala R; Baffour R; Hellinga D; Seabron R; Tio FO; Wittchow E; Tittelbach M; Diener T; Harder C; Virmani R; Jones R
    Cardiovasc Revasc Med; 2007; 8(4):259-74. PubMed ID: 18053948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Liang HF; Chen CT; Chen SC; Kulkarni AR; Chiu YL; Chen MC; Sung HW
    Biomaterials; 2006 Mar; 27(9):2051-9. PubMed ID: 16307794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.
    Huang Y; Salu K; Wang L; Liu X; Li S; Lorenz G; Wnendt S; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I
    J Invasive Cardiol; 2005 Mar; 17(3):142-8. PubMed ID: 15867441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.